WHO
WE
ARE
We are a biotechnology company advancing human-relevant organoid and organ-on-a-chip platforms to improve the predictiveness of preclinical research. Through integrated stem cell biology and microphysiological engineering, we deliver robust models that accelerate drug discovery and translational science.
Our Products
What We Offer
We provide ready-to-use organoids, tissue chips, multi-organ systems, and optimized reagents for high-fidelity in vitro modeling.
WHAT WE DO
We develop and deliver human-relevant organoid, organ-on-chip, and multi-organ systems, complemented by integrated pharmacology, DMPK, and analytical services. Our platforms enable more predictive discovery, safety assessment, and translational research.
Our Services
MODEL
DEVELOPMENT
Build human-relevant models with confidence. Our advanced organoid and organ-on-chip development platforms recreate tissue complexity and physiological function, enabling more predictive disease modeling and translational research from day one.
PHARMACOLOGY
& DMPK
Make better drug decisions earlier. By combining human-derived models with integrated pharmacology and DMPK assessments, we deliver actionable insights into efficacy, safety, and drug behavior—bridging the gap between in vitro testing and clinical outcomes.
ANALYTICAL
& READOUT
Turn complex biology into clear answers. Our high-resolution analytical and readout services uncover functional and molecular responses within 3D systems, transforming rich datasets into insights that drive discovery and development forward.
ABOUT
US
We are committed to transforming biomedical research through human-centric model systems engineered for higher biological relevance. Combining deep expertise in stem cell biology, microfluidics, and translational sciences, our team advances platforms that bridge the gap between in vitro studies and clinical reality. Our mission is to enable more predictive drug development and accelerate breakthroughs that improve human health.
Applications
Disease Areas
Therapeutic
Development
